Cinven looks to take Synlab private as Covid boost falters

Frankfurt-listed Synlab could be about to be taken private following a non-binding full takeover offer earlier this week. With its full year results released yesterday and facing questions about its plans, HBI asks market experts what they think of the move.

Cinven looking to take Synlab private

London headquartered global PE firm Cinven has submitted a non-binding offer to fully take over Europe's largest lab group Synlab, the company confirmed today, following speculation it was looking to take the group private.

Portuguese competition authority goes after labs

Portugal’s competition authority (AdC) has opened an investigation into collusion it suspects took place between several of the country’s major labs groups during the years 2016 and 2022. The accused groups include Affidea, Synlab and Unilabs subsidiaries.

Eugin enters Portugal

Spain-based fertility provider Eugin Group, part of Germany-based hospital group Fresenius Helios, is entering the Portuguese market.

Affidea subsidiary IMI denies cartel involvement, whilst Unilabs accepts fine

Portugal’s competition authority has accused the country's four largest teleradiology groups of involvement in a cartel for public hospital teleradiology tenders during the years 2015 to 2018. The companies involved include Unilabs subsidiary Dr. Campos Costa, which has admitted involvement, and Affidea subsidiary Imagens Médicas Integradas, which denies involvement.

Orpea pledges to pay in full as restructuring rumours continue

French elderly care giant Orpea continues to hit the headlines for all the wrong reasons. Over the last week, dozens of facilities were raided by the French authorities, talk continues to be rife about restructuring and potential exits, and contrary to previous assertions HBI understands the group now intends to pay back the full €56m owed to the state.

Lusiadas deal still on as seller carries cost of muti-million fine

The planned acquisition of Lusiadas Saude, Portugal's third largest hospital group, by France's third largest hospital group Vivalto Sante, will not be impacted by the €34.2m fine that has been handed to Lusiadas by Portugal's competition authority.

Find Us